Sponsor Name: Eli Lilly and Company
Protocol Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study Evaluating
LY3848575 in Chronic Neuropathic Pain Associated with Distal Sensory Polyneuropathy
Protocol Number: J4F-MC-CYAB
Regulatory Agency Identifier Numbers: IND: 162737; EU trial number: 2024-513435-24-00
Brief Summary: The purpose of this study is to evaluate how safe and how well a treatment works compared to placebo for people with nerve pain that begins in their feet and moves up the leg to just below the knee. Participation may last up to 30 weeks including screening.
https://clinicaltrials.gov/study/NCT06568042